Top compounds associated with response to LINC00521


Feature Type Standardized
Nominal ANOVA
mRNA ISOX CTRPv2 pan-cancer AAC -0.041 0.2
mRNA OSI-027 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.086 0.2
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.059 0.2
mRNA ATRA CTRPv2 pan-cancer AAC -0.044 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA CIL55A CTRPv2 pan-cancer AAC -0.062 0.2
Download CSV